Cite
Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers
MLA
Marc van Beurden, et al. “Peritoneal Carcinomatosis after Risk-Reducing Surgery in BRCA1/2 Mutation Carriers.” Cancer, vol. 124, Jan. 2018, pp. 952–59. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........762769771b3130954933e7783f0721b8&authtype=sso&custid=ns315887.
APA
Marc van Beurden, Jurgen M.J. Piek, Timothy R. Rebbeck, Leon F.A.G. Massuger, Mark H. Greene, Murray Joseph Casey, Nicoline Hoogerbrugge, Marline G. Harmsen, Joanne A. de Hullu, Brigitte F. M. Slangen, Johan Bulten, & Marian J.E. Mourits. (2018). Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers. Cancer, 124, 952–959.
Chicago
Marc van Beurden, Jurgen M.J. Piek, Timothy R. Rebbeck, Leon F.A.G. Massuger, Mark H. Greene, Murray Joseph Casey, Nicoline Hoogerbrugge, et al. 2018. “Peritoneal Carcinomatosis after Risk-Reducing Surgery in BRCA1/2 Mutation Carriers.” Cancer 124 (January): 952–59. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........762769771b3130954933e7783f0721b8&authtype=sso&custid=ns315887.